- Schizophrenia is a type of a chronic disorder that has an undesirable effect on an entity's lifestyle. Schizophrenic patients abnormally construe reality. The disorder results in a variety of behavioural changes that comprise the grouping of delusions and hallucinations
- Schizophrenia treatment is a lifetime procedure, and the medication used for treating schizophrenia controls the activities of patients
- North America is expected to dominate the Schizophrenia Treatments market due to advanced healthcare infrastructure, high healthcare expenditure, and robust research and development activities
- Asia-Pacific is expected to be the fastest growing region in the Schizophrenia Treatment market driven by increasing healthcare investments and improving infrastructure
- Second generation segment is expected to dominate the market with a market share of 72.62% due to their improved safety and efficacy profiles compared to first-generation antipsychotics. These newer drugs, also known as atypical antipsychotics, are associated with a lower risk of extrapyramidal symptoms, such as tremors and rigidity, which are common side effects of older medications
